Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 200
- Registration Number
- NCT00993967
- Locations
- 🇫🇷
Hôpital de la Salpétrière - INSERM U679, Neurologie et Thérapeutique expérimentale, Paris, France
🇩🇪Zentrum für Neurologische Medizin, Göttingen, Germany
🇩🇪HELIOS Klinikum Berlin, Berlin, Germany
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 232
- Registration Number
- NCT00905268
- Locations
- 🇫🇷
Hôpital de la Salpêtrière - INSERM U679, Neurologie et Thérapeutique expérimentale, Paris, France
🇩🇪Neurologische Klinik- klinikum Grosshadern, München, Germany
🇬🇧National Hospital for Neurology & Neurosurgery, London, United Kingdom
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 21
- Registration Number
- NCT00758225
- Locations
- 🇧🇪
University Hospitals Leuven, Leuven, Belgium
Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 85
- Registration Number
- NCT00747487
- Locations
- 🇨🇦
Unité de recherche clinique Ophtalmologie- Hopital Notre-Dame, Montreal, Quebec, Canada
🇬🇧Clinical Research Facility, 4th Floor Leazes Wing, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
🇩🇪Klinikum der Universität München - Grosshadern, Neurologische Klinik und Poliklinik, Munich, Germany
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 68
- Registration Number
- NCT00697073
- Locations
- 🇺🇸
David Geffen School of Medicine, UCLA, Los Angeles, California, United States
🇺🇸The Children's Hopsital of Philadelphia, Philadelphia, Pennsylvania, United States
Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy
- Conditions
- Interventions
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2011-08-01
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 21
- Registration Number
- NCT00654784
- Locations
- 🇧🇪
Children's Hospital, University Hospital, Leuven, Belgium
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Santhera Pharmaceuticals
- Target Recruit Count
- 70
- Registration Number
- NCT00537680
- Locations
- 🇺🇸
David Geffen School of Medicine, UCLA, Los Angeles, California, United States
🇺🇸The Children's Hopsital of Philadelphia, Philadelphia, Pennsylvania, United States